EI
MGNX icon

EAM Investors’s MacroGenics MGNX Stock Holding History

EAM Investors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$793K Buy
+171,705
New +$649K 0.07% 247
2015
Q2 		– Sell
-128,176
Closed -$4.02M – 355
2015
Q1 		$4.02M Buy
128,176
+13,137
+11% +$445K 0.46% 47
2014
Q4 		$4.03M Buy
+115,039
New +$2.87M 0.56% 27
2014
Q2 		– Sell
-32,451
Closed -$903K – 346
2014
Q1 		$903K Buy
+32,451
New +$1.15M 0.16% 303

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

EAM Investors's MGNX Position: Q2 2026 in Review

EAM Investors opened a new position in MacroGenics (MGNX) in Q2 2026: 171,705 shares worth $793K. The stake represents 0.07% of the portfolio and ranks #247 among its holdings. This is a return to the name: EAM Investors previously reported a position in MGNX as recently as Q1 2015.

EAM Investors first reported a position in MGNX in Q1 2014 and has held it in 4 quarters since. The position peaked at $4.03M in Q4 2014. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • EAM Investors held 171,705 shares of MacroGenics worth $793K as of Q2 2026.
  • MacroGenics was a new EAM Investors position in Q2 2026.
  • MacroGenics made up 0.07% of EAM Investors's portfolio in Q2 2026, its #247 holding.
  • EAM Investors first reported a position in MacroGenics in Q1 2014 and has held it in 4 quarters since.
  • EAM Investors's MacroGenics position peaked at $4.03M in Q4 2014.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.